Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for depression in chronic systolic heart failure
ACTRN12610000223033Phase 4Completed
- Sponsor
- Austin Health
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Escitalopram with Placebo (2 arms). Primary endpoints: Change in Cardiac Depression Scale score and Change in GRID-HAM-D-17 score. Started Oct 2010; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12610000223033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000223033.